Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors

mRNA vaccines have been shown to be safe and effective in individuals with cancer. It is unclear, however, if systemic anti-cancer therapy impacts the coordinated cellular and humoral immune responses elicited by SARS-CoV-2 mRNA vaccines. To fill this knowledge gap, we assessed SARS-CoV-2 mRNA vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Waickman, Adam T., Lu, Joseph, Chase, Corey, Fang, Hengsheng, McDowell, Erinn, Bingham, Erin, Bogart, Jeffrey, Graziano, Stephen, Thomas, Stephen J., Gentile, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144031/
https://www.ncbi.nlm.nih.gov/pubmed/35632494
http://dx.doi.org/10.3390/vaccines10050738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144031/
https://www.ncbi.nlm.nih.gov/pubmed/35632494
http://dx.doi.org/10.3390/vaccines10050738

Ejemplares similares